Building a Biologics Business from the Ground Up

Published: 27.07.2018

Hannes Teissl, CEO Biologics and Corporate Vice President of Polpharma Biologics, discusses how Polpharma established a fully integrated biologics business in the latest issue of Pharma’s Almanac. Learn more about the strategy behind our modular one-stop-shop model and how Polpharma Biologics is leveraging 80 years of experience to develop much needed biologic and biosimilar therapies.

Read full article here

written by: Polpharma Biologics

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.